Skip to Content
Merck
All Photos(1)

Key Documents

More Documents

Safety Information

MAB8251

Sigma-Aldrich

Anti-Influenza A Antibody, nucleoprotein, clones A1, A3 Blend

ascites fluid, Chemicon®, from mouse

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

mouse

Quality Level

300

antibody form

ascites fluid

antibody product type

primary antibodies

clone

A1, monoclonal
A3, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG1 (A3)
IgG2a (A1)

shipped in

wet ice

Specificity

All subtypes of Influenza A (H1N1, H2N2 and H3N2 and H5N1). Specific for the nucleoprotein antigen. No cross-reactivity seen to Influenza B, Parainfluenza 1, 2 or Adenovirus or RSV.

Immunogen

Influenza A blend.

Application

Indirect immunofluorescence at 1:100-1:1000.

Optimal working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
This Anti-Influenza A Antibody, nucleoprotein, clones A1, A3 Blend is validated for use in IF for the detection of Influenza A.

Physical form

Ascites fluid containing no preservatives.
Unpurified

Storage and Stability

Maintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Analysis Note

Control
Influenza Control Slides, Catalogue Number 5010-5

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

nwg

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

MAB8251:

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.
McCullers, JA; Van De Velde, LA; Allison, KJ; Branum, KC; Webby, RJ; Flynn, PM
Clinical Infectious Diseases null
Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: kinetics from epithelial cell culture and computational modeling.
Mitchell, H; Levin, D; Forrest, S; Beauchemin, CA; Tipper, J; Knight, J; Donart et al.
Journal of virology null
Maren Eggers et al.
Infectious diseases and therapy, 7(2), 249-259 (2018-04-11)
Recent virus epidemics and rising antibiotic resistance highlight the importance of hygiene measures to prevent and control outbreaks. We investigated the in vitro bactericidal and virucidal efficacy of povidone-iodine (PVP-I) 7% gargle/mouthwash at defined dilution against oral and respiratory tract
Tissue tropism of a Thailand strain of high-pathogenicity avian influenza virus (H5N1) in tissues of naturally infected native chickens (Gallus gallus), Japanese quail (Coturnix coturnix japonica) and ducks (Anas spp.).
Chongmas Antarasena, Rungtiva Sirimujalin, Porntip Prommuang, Stuart D Blacksell et al.
Avian Pathology : Journal of the W.V.P.A null
Rapidly produced SAM(?) vaccine against H7N9 influenza is immunogenic in mice.
Hekele, A; Bertholet, S; Archer, J; Gibson, DG; Palladino, G; Brito, LA; Otten et al.
Emerging microbes & infections null
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service